Recurrent multiterritorial ischemic stroke with persistent moderate hypereosinophilia: A case report with focused literature review
- 1Department of Neurology, Central Hospital, Tianjin University/Tianjin Third Central Hospital, China
- 2Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, China
- 3Tianjin Artificial Cell Engineering Technology Research Center, China
Abstract
Persistent hypereosinophilia may be overlooked during stroke evaluation when conventional vascular risks coexist. We report the case of a man in his late 50s who had hypertension, type 2 diabetes, continued active smoking, and eight clinically apparent magnetic resonance imaging–confirmed strokes in multiple bilateral territories over 29 months. Before systemic glucocorticoid exposure, absolute eosinophil counts ranged from 1.87 to 3.23 × 109/L on repeated measurements. Bone marrow morphology and flow cytometry revealed eosinophil expansion without aberrancy, and common tested clonal drivers were negative. Transthoracic echocardiography, two 24-h Holter recordings, and a bubble study identified no intracardiac source. Aortic computed tomography angiography in April 2026 demonstrated thoracic aortic atherosclerosis with calcified plaques and focal ulceration; transesophageal echocardiography and prolonged rhythm monitoring were not performed. A new left pontine infarct occurred in April 2026 while he was on oral prednisone (20 mg/day). In August 2026, after systemic glucocorticoid withdrawal despite continued inhaled budesonide/formoterol, a new right temporal infarct occurred, with an absolute eosinophil count of 2.66 × 109/L. Worsening wheeze suggested possible eosinophilic airway inflammation; however, emphysema alone did not explain systemic eosinophilia, and eosinophilic granulomatosis with polyangiitis remained unproven. The available evidence favored a multifactorial interpretation; eosinophilia provides biological plausibility, whereas conventional vascular risks and an incompletely characterized thoracic aortic abnormality remain competing explanations. Persistent eosinophilia should prompt repeated etiological reassessment without inferring causality based on blood count or imaging pattern alone.
Related
- Serial measurements of Growth Differentiation Factor-15 in patients with Non-ST-Elevation Acute Coronary Syndrome and recurrent ischemic events
- Serum MGP and ECP are commonly elevated in first-onset and recurrent ischemic stroke: a two-phase DIA proteomic study in a Chinese cold-region cohort
- Recurrent thymoma-associated PRCA with persistent agranulocytosis: a case report and therapeutic considerations
- Recurrent Ischemic Stroke after Carotid Artery Stenting for Thyroid Cartilage Induced CCA Stenosis: Was Stenting an Appropriate Treatment?
- A Case of MEN 2A Syndrome With Bilateral Recurrent Pheochromocytoma: A Case Report and Literature Review
BibTeX
@article{wang2026recurrent,
title = {{Recurrent multiterritorial ischemic stroke with persistent moderate hypereosinophilia: A case report with focused literature review}},
author = {Yu Wang and Na Liu and Ju Zhu},
journal = {The Journal of International Medical Research},
year = {2026},
month = sep,
doi = {10.1177/03000605261491519},
url = {https://doi.org/10.1177/03000605261491519},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Recurrent multiterritorial ischemic stroke with persistent moderate hypereosinophilia: A case report with focused literature review
AU - Yu Wang
AU - Na Liu
AU - Ju Zhu
PY - 2026
DA - 2026/09/28
JO - The Journal of International Medical Research
DO - 10.1177/03000605261491519
UR - https://doi.org/10.1177/03000605261491519
AB - Persistent hypereosinophilia may be overlooked during stroke evaluation when conventional vascular risks coexist. We report the case of a man in his late 50s who had hypertension, type 2 diabetes, continued active smoking, and eight clinically apparent magnetic resonance imaging–confirmed strokes in multiple bilateral territories over 29 months. Before systemic glucocorticoid exposure, absolute eosinophil counts ranged from 1.87 to 3.23 × 109/L on repeated measurements. Bone marrow morphology and flow cytometry revealed eosinophil expansion without aberrancy, and common tested clonal drivers were negative. Transthoracic echocardiography, two 24-h Holter recordings, and a bubble study identified no intracardiac source. Aortic computed tomography angiography in April 2026 demonstrated thoracic aortic atherosclerosis with calcified plaques and focal ulceration; transesophageal echocardiography and prolonged rhythm monitoring were not performed. A new left pontine infarct occurred in April 2026 while he was on oral prednisone (20 mg/day). In August 2026, after systemic glucocorticoid withdrawal despite continued inhaled budesonide/formoterol, a new right temporal infarct occurred, with an absolute eosinophil count of 2.66 × 109/L. Worsening wheeze suggested possible eosinophilic airway inflammation; however, emphysema alone did not explain systemic eosinophilia, and eosinophilic granulomatosis with polyangiitis remained unproven. The available evidence favored a multifactorial interpretation; eosinophilia provides biological plausibility, whereas conventional vascular risks and an incompletely characterized thoracic aortic abnormality remain competing explanations. Persistent eosinophilia should prompt repeated etiological reassessment without inferring causality based on blood count or imaging pattern alone.
SN - 0300-0605
SN - 1473-2300
ER -